Skip to main content
Felicitex Therapeutics Inc. (FLCT)
Felicitex Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price
$6.25
Shares Offered
2,480,000
Deal Size
$15.50M

Felicitex Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Net Income
-1.35-0.72
Depreciation & Amortization
00.14
Share-Based Compensation
0.34-
Other Operating Activities
0.12-0.4
Operating Cash Flow
-0.89-0.98
Capital Expenditures
--0
Investing Cash Flow
--0
Debt Issued / Paid
0.590.38
Other Financing Activities
0.270.63
Financing Cash Flow
0.861.01
Net Cash Flow
-0.030.03
Free Cash Flow
-0.89-0.98
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).